Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006-Reference-Cited by-同舟云学术

Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006

Published:2013-10-10 Issue:1 Volume:120 Page:86-95
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Nielsen Matthew E.¹²³,Smith Angela B.¹²,Meyer Anne-Marie¹³,Kuo Tzy-Mey¹,Tyree Seth¹,Kim William Y.¹⁴,Milowsky Matthew I.¹⁴,Pruthi Raj S.¹²,Millikan Robert C.¹³

Affiliation:

1. Lineberger Comprehensive Cancer Center; University of North Carolina; Chapel Hill North Carolina

2. Department of Urology; University of North Carolina School of Medicine; Chapel Hill North Carolina

3. Department of Epidemiology; University of North Carolina Gillings School of Global Public Health; Chapel Hill North Carolina

4. Division of Hematology/Oncology; University of North Carolina School of Medicine; Chapel Hill North Carolina

Funder

National Institutes of Health

University Cancer Research Fund

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference39 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin,2010

2. AUA Bladder Cancer Clinical Guidelines Panel Summary Report on the Management of Nonmuscle Invasive Bladder;Hall;Cancer,2010

3. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis;Riley;Med Care.,1995

4. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence, initial management and survival of high-risk non-muscle invasive bladder cancer in Northern France;The French Journal of Urology;2024-09

2. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;CA: A Cancer Journal for Clinicians;2024-04-04

3. Enhancing RECK Expression Through miR-21 Inhibition: A Promising Strategy for Bladder Carcinoma Control;Biochemical Genetics;2024-03-24

4. Practical Guide to VI-RADS: MRI Protocols, Lesion Characterization, and Pitfalls;RadioGraphics;2024-03-01

5. FGFR inhibition augments anti–PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression;Journal of Clinical Investigation;2024-01-16